CASEY JENNINGS: Open Payments
NPI 1033300488 · LOUISIANA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 50 payments from 17 companies in 2025. Trend: 2023 $1,213 · 2024 $770 · 2025 $1,058
Food & beverage: $865Education: $193
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $319 |
| Novo Nordisk Inc | 8 | $121 |
| ABBVIE INC. | 5 | $101 |
| Amgen Inc. | 5 | $79 |
| Viatris Specialty LLC | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| PFIZER INC. | 3 | $44 |
| ABIOMED | 1 | $41 |
| Lilly USA, LLC | 2 | $35 |
Products named: AUSTEDO XR, REXULTI, Wegovy, YUPELRI, OTEZLA, UBRELVY, COBENFY, NURTEC ODT.
Industry payments across MO — which companies pay providers there.
